Company Profile

　　Founded in 1995, Jiangxi Hongda Group is a large-scale enterprise specializing in the production of single-use sterile medical devices. With registered capital of RMB 428.88 million, the company boasts strong R&D and innovation capabilities. Its product portfolio encompasses eight major categories—syringes, infusion (blood) sets, puncture instruments, diagnostic aids, anesthesia equipment, catheters, comprehensive blood‑purification solutions, and multimodal smart healthcare information management systems—totaling an annual output of 4 billion units (sets) of disposable sterile medical devices. The company holds approximately 25% of the domestic market share and exports its products to international markets across Europe, the Americas, Asia, and Africa, positioning itself as a leading manufacturer and processor of consumables in China’s single-use medical device industry.

　　Hongda Group has successively been elected as an executive council member of the China Association for Medical Device Industry, a vice-chairman unit of the Medical Polymer Products Branch of the same association, and a member of the Standards Committee for Medical Polymer Products under the China Association for Medical Device Industry. It also serves as the president unit of the Jiangxi Provincial Medical Device Industry Association. The company is a key enterprise in Jiangxi Province and the leading enterprise in Nanchang’s medical device industry. It has received numerous honors, including National Civilized Unit, Advanced Enterprise in Epidemic Prevention and Control by the All-China Federation of Industry and Commerce, Jiangxi Famous Brand, Jiangxi Well-Known Trademark, Advanced Collective and Outstanding Individual in Epidemic Prevention and Control in Jiangxi Province, and Jiangxi Province‑level Enterprise Committed to Contractual Obligations and Reputable Practices.

　　Hongda Group has established the corporate mission of “focusing on core business operations and pursuing superior quality; building the Hongda brand to ensure peace of mind for both medical professionals and patients,” along with the management philosophy that “today’s product quality determines tomorrow’s market success; today’s customer satisfaction shapes Hongda’s future.” Furthermore, the company has adopted the quality policy: “Prioritize preventive safety in production, uphold rigorous management standards, and strive for meticulous craftsmanship; deliver products with excellent value and quality, provide sincere customer service, and foster a people‑centric culture driven by innovation; continuously improve to achieve world‑class excellence.”

　　Over the next five years, the Group plans to invest RMB 320 million to establish an innovation and R&D platform—the Hongda Postdoctoral Research Station—aiming to recruit 8–10 postdoctoral researchers and 120 R&D personnel holding at least a bachelor’s degree, aligned with industry needs. It will also forge comprehensive “industry–academia–research–application” partnerships with provincial-level Grade‑III hospitals, universities, and research institutes, leveraging innovation to drive industrial transformation and upgrading. This strategy will catalyze growth across four key sectors—infusion consumables, in vitro diagnostics (IVD), hemodialysis, and intelligent medical devices—ultimately realizing the vision of building the “Hongda Hongyun Hundred‑Billion‑Yuan Medical Industry Park.” The upgrade of Hongda Medical’s industrial capabilities will proceed along two main axes: first, transitioning from traditional labor‑intensive manual processes to automated and intelligent manufacturing technologies; and second, expanding into high‑value‑added products within the existing industrial value chain.

　　Seizing the momentum and riding the wave of opportunity, Hongda Group, with the care and support of governments at all levels and all sectors of society, will take triple‑pronged growth as its core driving force and aim to develop a ten‑billion‑yuan industrial park. Remaining true to our original aspirations, we will forge ahead with determination, contributing to the building of a prosperous, beautiful, and happy modern Jiangxi, and together paint a new chapter of this land’s abundant resources, splendid natural beauty, and outstanding people, achieving even greater successes and creating new glories!